High dose lopinavir/ritonavir does not lead to sufficient plasma levels to inhibit SARS-CoV-2 in hospitalized COVID-19 patients

被引：0
|
作者：
Karolyi, Mario [1 ]
Omid, Sara [1 ]
Pawelka, Erich [1 ]
Jilma, Bernd [2 ]
Stimpfl, Thomas [2 ]
Schoergenhofer, Christian [2 ]
Seitz, Tamara [1 ]
Traugott, Marianna [1 ]
Wenisch, Christoph [1 ]
Zoufaly, Alexander [1 ]
机构：
[1] Kaiser Franz Josef Spital Wien, Vienna, Austria
[2] AKH Wien, Vienna, Austria
来源：
INFECTION | 2021年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
061
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [1] High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19
    Karolyi, Mario
    Omid, Sara
    Pawelka, Erich
    Jilma, Bernd
    Stimpfl, Thomas
    Schoergenhofer, Christian
    Laferl, Hermann
    Seitz, Tamara
    Traugott, Marianna
    Wenisch, Christoph
    Zoufaly, Alexander
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [2] Does lopinavir really inhibit SARS-CoV-2?
    Cattaneo, Dario
    Cattaneo, Dario
    Gervasoni, Cristina
    Corbellino, Mario
    Galli, Massimo
    Riva, Agostino
    Gervasoni, Cristina
    Clementi, Emilio
    Clementi, Emilio
    PHARMACOLOGICAL RESEARCH, 2020, 158
  • [3] SARS-CoV-2 and HIV protease inhibitors: why lopinavir/ritonavir will not work for COVID-19 infection
    Smolders, Elise J.
    Brake, Lindsey Hm Te
    Burger, David M.
    ANTIVIRAL THERAPY, 2020, 25 (07) : 345 - 347
  • [4] SARS-CoV-2 viral dynamics and population pharmacokinetics of favipiravir in combination with lopinavir-ritonavir in patients with COVID-19
    Agyeman, Akosua A.
    Brown, Li-An K.
    Guerra-Assuncao, Jose A.
    Breuer, Judy
    Lowe, David M.
    Standing, Joseph F.
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 291 - 294
  • [5] Suggesting Ritonavir against COVID-19/SARS-CoV-2
    Choudhury, Shuvasish
    Mazumder, Muhammed Khairujjaman
    MEDICAL HYPOTHESES, 2020, 140
  • [6] Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19
    Kim, Min-Chul
    Cui, Chunguang
    Shin, Kyeong-Ryeol
    Bae, Joon-Yong
    Kweon, Oh-Joo
    Lee, Mi-Kyung
    Choi, Seong-Ho
    Jung, Sun-Young
    Park, Man-Seong
    Chung, Jin-Won
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (07): : 671 - +
  • [7] How Does Vaccination against SARS-CoV-2 Affect Hospitalized Patients with COVID-19?
    Moreno-Nunez, Paloma
    Bueno-Cavanillas, Aurora
    San Jose-Saras, Diego
    Vicente-Guijarro, Jorge
    Fernandez Chavez, Abelardo Claudio
    Aranaz-Andres, Jesus Maria
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
  • [8] High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients
    Chenane, Houssem Redha
    Lingas, Guillaume
    Menidjel, Reyene
    Laouenan, Cedric
    Tubiana, Sarah
    Descamps, Diane
    Le Hingrat, Quentin
    Abel, Laurent
    Guedj, Jeremie
    Malhotra, Surbhi
    Kumar-Singh, Samir
    Visseaux, Benoit
    Ghosn, Jade
    Charpentier, Charlotte
    Lebourgeois, Samuel
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (11)
  • [9] Plasma SARS-CoV-2 Nucleocapsid Antigen Levels Are Associated With In-hospital Mortality in Hospitalized Patients With COVID-19
    Sullivan, K.
    Zhuo, H.
    Caldwell, E.
    Thompson, B.
    Rogers, A.
    Baron, R. M.
    Wick, K. D.
    Aggarwal, N. R.
    Calfee, C. S.
    Dewar, R.
    Shaw-Saliba, K.
    Lane, H.
    Highbarger, H.
    Lallemand, P.
    Hough, C.
    Matthay, M. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [10] Electroencephalographic findings in hospitalized patients with SARS-COV-2 (COVID-19) encephalopathy
    Samudra, Niyatee
    Roberson, Shawniqua Williams
    NEUROLOGY, 2021, 96 (15)
12345